Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China
Recent reports suggesting that pharma giants Novo Nordisk NVO and Eli Lilly LLY have lowered prices for their blockbuster obesity drugs, Wegovy and Mounjaro, in China, have sent ripples through the healthcare sector. List prices for certain Wegovy dosages in specific Chinese provinces were reported…
Recent reports suggesting that pharma giants Novo Nordisk NVO and Eli Lilly LLY have lowered prices for their blockbuster obesity drugs, Wegovy and Mounjaro, in China, have sent ripples through the healthcare sector. List prices for certain Wegovy dosages in specific Chinese provinces were reported…
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
